-
EP4229081
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4229081
| EP4229081 - ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 21.07.2023 Database last updated on 24.07.2024 | |
| Former | The international publication has been made Status updated on 22.04.2022 | ||
| Former | unknown Status updated on 19.11.2021 | Most recent event Tooltip | 22.12.2023 | Change: Validation states | published on 24.01.2024 [2024/04] | 22.12.2023 | Change - extension states | published on 24.01.2024 [2024/04] | Applicant(s) | For all designated states The United States of America, as represented by The Secretary, Department of Health and Human Services Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive, Suite 700, MSC 7788 Bethesda, Maryland 20892-7788 / US | [2023/34] | Inventor(s) | 01 /
SADTLER, Kaitlyn Noelle Bethesda, Maryland 20894 / US | 02 /
MEMOLI, Matthew James Bethesda, Maryland 20892 / US | [2023/34] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE | [2023/34] | Application number, filing date | 21802499.0 | 08.10.2021 | [2023/34] | WO2021US54281 | Priority number, date | US202063092350P | 15.10.2020 Original published format: US 202063092350 P | US202163225248P | 23.07.2021 Original published format: US 202163225248 P | [2023/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022081436 | Date: | 21.04.2022 | Language: | EN | [2022/16] | Type: | A1 Application with search report | No.: | EP4229081 | Date: | 23.08.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.04.2022 takes the place of the publication of the European patent application. | [2023/34] | Search report(s) | International search report - published on: | EP | 21.04.2022 | Classification | IPC: | C07K16/10 | [2023/34] | CPC: |
C07K16/1002 (EP,US);
C07K16/1003 (EP,US);
C07K2317/24 (US);
C07K2317/30 (US);
C07K2317/52 (EP);
C07K2317/76 (US);
C07K2317/92 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/34] | Title | German: | FÜR SARS-COV-2-REZEPTOR-BINDUNGSDOMÄNE SPEZIFISCHER ANTIKÖRPER UND THERAPEUTISCHE VERFAHREN | [2023/34] | English: | ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS | [2023/34] | French: | ANTICORPS SPÉCIFIQUE DU DOMAINE DE LIAISON DU RÉCEPTEUR DU SARS-COV-2 ET PROCÉDÉS THÉRAPEUTIQUES | [2023/34] | Entry into regional phase | 15.05.2023 | National basic fee paid | 15.05.2023 | Designation fee(s) paid | 15.05.2023 | Examination fee paid | Examination procedure | 15.05.2023 | Examination requested [2023/34] | 15.05.2023 | Date on which the examining division has become responsible | 15.12.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 23.10.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2011135664 (MUELLER BERNHARD K [DE]); | [Y]WO2016160618 (UNIV SOUTHERN CALIFORNIA [US]); | [XY]US10787501 (BABB ROBERT [US], et al); | by applicant | US3645090 | US3720760 | US3773919 | US3940475 | EP0036676 | EP0052322 | EP0058481 | EP0088046 | DE3218121 | US4474893 | US4485045 | EP0142641 | EP0143949 | US4544545 | EP0171496 | EP0173494 | WO8601533 | US4631211 | WO8702671 | US4714681 | US4737456 | US4816567 | US4816397 | WO8912624 | WO9002809 | US4925648 | EP0396387 | WO9100360 | EP0413622 | WO9109967 | WO9110737 | WO9114438 | WO9201047 | WO9205793 | WO9208802 | WO9208495 | WO9218619 | WO9222324 | WO9311161 | WO9311236 | US5223409 | US5225539 | WO9317715 | US5314995 | EP0598877 | US5403484 | US5413923 | WO9515982 | US5427908 | WO9520401 | US5516637 | US5530101 | WO9622024 | US5545806 | US5565332 | US5569825 | WO9634096 | WO9633735 | US5571698 | US5573920 | US5580717 | US5585089 | US5601819 | WO9713844 | US5625126 | US5633425 | US5658727 | US5661016 | US5698426 | US5733743 | US5750753 | WO9824893 | US5766883 | US5780225 | US5807715 | US5814318 | US5821047 | WO9904813 | US5876969 | US5885793 | US5916771 | US5939598 | US5969108 | JP2008118008 | WO1991GB01134 |